GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
2020-04-29 $17.65 $18.35 $17.36 $18.18 2 163 323
2020-04-28 $19.04 $19.31 $17.53 $17.57 829 396
2020-04-27 $18.37 $19.09 $18.07 $18.42 908 677
2020-04-24 $16.78 $17.75 $16.49 $17.64 563 577
2020-04-23 $17.28 $17.71 $16.74 $16.83 935 186
2020-04-22 $16.49 $17.35 $16.25 $17.07 924 553
2020-04-21 $16.40 $17.05 $16.08 $16.11 1 074 790
2020-04-20 $15.83 $16.25 $15.39 $16.87 1 052 300
2020-04-17 $15.83 $16.25 $15.39 $16.24 1 051 732
2020-04-16 $15.62 $15.68 $14.65 $15.24 940 454
2020-04-15 $15.51 $15.90 $14.95 $15.61 1 076 059
2020-04-14 $16.29 $16.79 $15.76 $15.90 1 121 469
2020-04-13 $16.00 $16.26 $15.27 $16.04 771 594
2020-04-09 $16.32 $16.84 $15.61 $16.02 1 479 220
2020-04-08 $15.07 $16.42 $14.87 $15.86 1 449 476
2020-04-07 $14.50 $15.50 $14.36 $14.81 1 743 190
2020-04-06 $13.96 $14.89 $13.73 $14.08 1 030 339
2020-04-03 $13.74 $14.29 $13.12 $13.36 1 610 600
2020-04-02 $13.50 $13.95 $13.30 $13.94 887 995
2020-04-01 $13.95 $14.55 $13.47 $13.61 1 431 741
2020-03-31 $14.59 $15.30 $14.02 $14.42 1 413 928
2020-03-30 $14.00 $14.59 $13.42 $14.55 1 452 168
2020-03-27 $13.90 $14.54 $13.42 $13.98 978 440
2020-03-26 $13.94 $14.98 $13.63 $14.44 1 443 342
2020-03-25 $14.05 $14.49 $13.33 $13.85 1 830 986
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT